Dr. Kathleen S. Wilson is the Director of the Cytogenomic Microarray Analysis (CMA) laboratory in the Genetic Diagnostics Laboratories. She established the first CMA Laboratory for patient diagnostics in North Texas in 2008, bringing this technologically advanced form of high resolution chromosome analysis for clinical care to UT Southwestern and the North Texas region. She completed her undergraduate education at Amherst College and graduated with honors in 1986. She received her medical degree in 1991 from The University of Texas Southwestern Medical Center at Dallas. She subsequently completed pathology residency and genetics fellowship training also at UT Southwestern.
Dr. Wilson is a faculty member in the Department of Pathology and the McDermott (Genetics) Center for Human Growth and Development. She is board-certied by the American Board of Pathology (ABP) in Clinical Pathology and the American Board of Medical Genetics (ABMG) in Clinical Cytogenetics. She is also a fellow of the College of American Pathologists (CAP) and the American College of Medical Genetics (ACMG).
She has served on the Cytogenetics Resource Committee (CyRC) of the CAP and ACMG for over a decade and was involved in setting national policy for cytogenetics and molecular cytogenomics by developing accreditation guidelines and issuing proficiency testing. She has served as chair of the Economics of Genetic Services Committee for ACMG and has also been an active participant nationally in policy related to reimbursement for high complexity genetic testing. She is currently involved in multiple medical school administrative and educational activities in her roles as Chair of the UT Southwestern Medical School Admissions Committee and Co-Director of the Medical Student Genetics Course.
Dr. Wilson has won teaching awards and has been actively involved in the teaching and mentorship of medical and graduate students, house staff, and junior faculty for over twenty-five years. In addition to the publications below, Dr. Wilson has contributed to book chapters in Abeloff: Clinical Oncology, 4th ed., Clinical Laboratory Hematology, 3rd ed. and Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease, 5th ed.
Cheng E, Zhang X, Wilson KS, Wang DH, Park JY, Huo X, Yu C, Zhang Q, Spechler SJ, Souza RF. JAK-STAT6 Pathway Inhibitors Block Eotaxin-3 Secretion by Epithelial Cells and Fibroblasts from Esophageal Eosinophilia Patients: Promising Agents to Improve Inflammation and Prevent Fibrosis in EoE. PLoS One. 2016
Lewis CM, Bu D, Sarode V, Robinson L, Wilson KS, Viscusi RK, Eng C, Euhus DM. The clinical consequences of hemizygosity across 2 MB of 10q23 are restricted to Cowden syndrome. Breast Cancer Res Treat. 2012
Brothman AR, Dolan MM, Goodman BK, Park JP, Persons DL, Saxe DF, Tepperberg JH, Tsuchiya KD, Van Dyke DL, Wilson KS, Wolff DJ, Theil KS. College of American Pathologists/American College of Medical Genetics proficiency testing for constitutional cytogenomic microarray analysis. Genet Med. 2011